MentionFox
Home › Executive changes › Sunshine Biopharma Inc.
Leadership changes · SBFM · SEC Form 8-K, Item 5.02

Leadership changes at Sunshine Biopharma Inc. (2026)

Before you join, sell to or invest in Sunshine Biopharma Inc.

MentionFox check on Sunshine Biopharma Inc.: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/sunshine-biopharma

Check Sunshine Biopharma Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Sunshine Biopharma Inc.?

Who joined and who left Sunshine Biopharma Inc. (SBFM)? 1 departure reported on 2026-02-05, each cited to the company's own filing.

As of November 15, 2026, Sunshine Biopharma Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 5, 2026, naming 1 departure. The latest filing names Abderrazzak Merzouki, leaving (Form 8-K, February 5, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Altium Capital Management LLC also filed stake reports on 5 other companies ↓

Sell to companies like Sunshine Biopharma Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Out (departing)1
Latest filing2026-02-05

Sunshine Biopharma Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-05. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Sunshine Biopharma Inc. files it.

Also on the record for Sunshine Biopharma Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G/A, by Mitchell P. Kopin9.99% of the class5%+ stakesSource
October 14, 2026Stake report, Schedule 13G, by BJI Financial Group6% of the class5%+ stakesSource
October 13, 2026Stake report, Schedule 13G, by CVI Investments, Inc.9.9% of the class5%+ stakesSource
October 5, 2026Stake report, Schedule 13G/A, by Alta Partners LLC4.9% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by L1 Capital Global Opportunities Master Fund, Ltd.4.99% of the class5%+ stakesSource
August 13, 2026Stake report, Schedule 13G/A, by Mitchell P. Kopin9.99% of the class5%+ stakesSource
July 8, 2026Stake report, Schedule 13G, by Alta Partners LLC8.6% of the class5%+ stakesSource
May 22, 2026Stake report, Schedule 13G, by L1 Capital Global Opportunities Master Fund, Ltd.5.83% of the class5%+ stakesSource
May 21, 2026Stake report, Schedule 13G, by Bigger Michael9.47% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Altium Capital Management LLC—5%+ stakesSource

Selling to them or working with them? See who runs Sunshine Biopharma Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Sunshine Biopharma Inc. and the records around it.

Sunshine Biopharma Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Sunshine Biopharma Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Sunshine Biopharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Sunshine Biopharma Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-05Out8-K, 2026-02-05

Why did they leave? What the filings say

Sunshine Biopharma Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.

Selling to Sunshine Biopharma Inc.?

New leaders reset buying decisions — get the Full Report on Sunshine Biopharma Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Sunshine Biopharma Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Sunshine Biopharma Inc., with the record behind each one.

Find candidates like senior executive at Sunshine Biopharma Inc.

Every change, in the filing's words

Filed 2026-02-05 · 8-K

Departing: Abderrazzak Merzouki

On February 5, 2026, Dr. Abderrazzak Merzouki resigned as chief operating officer of Sunshine Biopharma Inc., effective immediately. 2

Tools for this story

Each opens in a new tab, filled in for Sunshine Biopharma Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/sunshine-biopharma
Last updated 2026-11-15
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Sunshine Biopharma Inc. executive departure 2026. MentionFox, 2026-11-15. https://mentionfox.com/executive-changes/sunshine-biopharma